EMEA (Europe, Middle East and Africa) PDE Inhibitors Market Report 2017

November 2017 | 105 pages | ID: E64607E9263EN
QYResearch

Abstracts

In this report, the EMEA PDE Inhibitors market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (), revenue (Million USD), market share and growth rate of PDE Inhibitors for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA PDE Inhibitors market competition by top manufacturers/players, with PDE Inhibitors sales volume (), price (), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Hanmi Science Holding
• Boehringer Ingelheim
• Takeda Pharmaceuticals
• Pfizer
• Omeros
• Anacor Pharmaceuticals
• Otsuka
• Chiesi Farmaceutici
• Verona Pharma
• NuSirt Biopharma

On the basis of product, this report displays the sales volume (), revenue (Million USD), product price (), market share and growth rate of each type, primarily split into

• PDE5
• PDE4
• Viagra
• Cialis
• Levitra
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (), market share and growth rate of PDE Inhibitors for each application, including

• GENITOURINARY
• CARDIOVASCULAR DISEASES
• NEUROLOGICAL DISEASES
• DERMATOLOGICAL DISORDERS
• RESPIRATORY DISEASES
• OTHER INDICATIONS

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) PDE Inhibitors Market Report 2017

1 PDE INHIBITORS OVERVIEW

1.1 Product Overview and Scope of PDE Inhibitors
1.2 Classification of PDE Inhibitors
  1.2.1 EMEA PDE Inhibitors Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA PDE Inhibitors Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 PDE5
  1.2.4 PDE4
  1.2.5 Viagra
  1.2.6 Cialis
  1.2.7 Levitra
  1.2.8 Others
1.3 EMEA PDE Inhibitors Market by Application/End Users
  1.3.1 EMEA PDE Inhibitors Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 GENITOURINARY
  1.3.3 CARDIOVASCULAR DISEASES
  1.3.4 NEUROLOGICAL DISEASES
  1.3.5 DERMATOLOGICAL DISORDERS
  1.3.6 RESPIRATORY DISEASES
  1.3.7 OTHER INDICATIONS
1.4 EMEA PDE Inhibitors Market by Region
  1.4.1 EMEA PDE Inhibitors Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of PDE Inhibitors (2012-2022)
  1.5.1 EMEA PDE Inhibitors Sales and Growth Rate (2012-2022)
  1.5.2 EMEA PDE Inhibitors Revenue and Growth Rate (2012-2022)

2 EMEA PDE INHIBITORS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA PDE Inhibitors Market Competition by Players/Manufacturers
  2.1.1 EMEA PDE Inhibitors Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA PDE Inhibitors Revenue and Share by Players (2012-2017)
  2.1.3 EMEA PDE Inhibitors Sale Price by Players (2012-2017)
2.2 EMEA PDE Inhibitors (Volume and Value) by Type/Product Category
  2.2.1 EMEA PDE Inhibitors Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA PDE Inhibitors Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA PDE Inhibitors Sale Price by Type (2012-2017)
2.3 EMEA PDE Inhibitors (Volume) by Application
2.4 EMEA PDE Inhibitors (Volume and Value) by Region
  2.4.1 EMEA PDE Inhibitors Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA PDE Inhibitors Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA PDE Inhibitors Sales Price by Region (2012-2017)

3 EUROPE PDE INHIBITORS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe PDE Inhibitors Sales and Value (2012-2017)
  3.1.1 Europe PDE Inhibitors Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe PDE Inhibitors Revenue and Growth Rate (2012-2017)
3.2 Europe PDE Inhibitors Sales and Market Share by Type
3.3 Europe PDE Inhibitors Sales and Market Share by Application
3.4 Europe PDE Inhibitors Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe PDE Inhibitors Sales Volume by Countries (2012-2017)
  3.4.2 Europe PDE Inhibitors Revenue by Countries (2012-2017)
  3.4.3 Germany PDE Inhibitors Sales and Growth Rate (2012-2017)
  3.4.4 France PDE Inhibitors Sales and Growth Rate (2012-2017)
  3.4.5 UK PDE Inhibitors Sales and Growth Rate (2012-2017)
  3.4.6 Russia PDE Inhibitors Sales and Growth Rate (2012-2017)
  3.4.7 Italy PDE Inhibitors Sales and Growth Rate (2012-2017)
  3.4.8 Benelux PDE Inhibitors Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PDE INHIBITORS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East PDE Inhibitors Sales and Value (2012-2017)
  4.1.1 Middle East PDE Inhibitors Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East PDE Inhibitors Revenue and Growth Rate (2012-2017)
4.2 Middle East PDE Inhibitors Sales and Market Share by Type
4.3 Middle East PDE Inhibitors Sales and Market Share by Application
4.4 Middle East PDE Inhibitors Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East PDE Inhibitors Sales Volume by Countries (2012-2017)
  4.4.2 Middle East PDE Inhibitors Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia PDE Inhibitors Sales and Growth Rate (2012-2017)
  4.4.4 Israel PDE Inhibitors Sales and Growth Rate (2012-2017)
  4.4.5 UAE PDE Inhibitors Sales and Growth Rate (2012-2017)
  4.4.6 Iran PDE Inhibitors Sales and Growth Rate (2012-2017)

5 AFRICA PDE INHIBITORS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa PDE Inhibitors Sales and Value (2012-2017)
  5.1.1 Africa PDE Inhibitors Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa PDE Inhibitors Revenue and Growth Rate (2012-2017)
5.2 Africa PDE Inhibitors Sales and Market Share by Type
5.3 Africa PDE Inhibitors Sales and Market Share by Application
5.4 Africa PDE Inhibitors Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa PDE Inhibitors Sales Volume by Countries (2012-2017)
  5.4.2 Africa PDE Inhibitors Revenue by Countries (2012-2017)
  5.4.3 South Africa PDE Inhibitors Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria PDE Inhibitors Sales and Growth Rate (2012-2017)
  5.4.5 Egypt PDE Inhibitors Sales and Growth Rate (2012-2017)
  5.4.6 Algeria PDE Inhibitors Sales and Growth Rate (2012-2017)

6 EMEA PDE INHIBITORS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Hanmi Science Holding
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 PDE Inhibitors Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Hanmi Science Holding PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Boehringer Ingelheim
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 PDE Inhibitors Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Boehringer Ingelheim PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Takeda Pharmaceuticals
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 PDE Inhibitors Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Takeda Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 PDE Inhibitors Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Omeros
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 PDE Inhibitors Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Omeros PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Anacor Pharmaceuticals
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 PDE Inhibitors Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Anacor Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Otsuka
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 PDE Inhibitors Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Otsuka PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Chiesi Farmaceutici
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 PDE Inhibitors Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Chiesi Farmaceutici PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Verona Pharma
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 PDE Inhibitors Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Verona Pharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 NuSirt Biopharma
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 PDE Inhibitors Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 NuSirt Biopharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 PDE INHIBITORS MANUFACTURING COST ANALYSIS

7.1 PDE Inhibitors Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of PDE Inhibitors

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 PDE Inhibitors Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of PDE Inhibitors Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PDE INHIBITORS MARKET FORECAST (2017-2022)

11.1 EMEA PDE Inhibitors Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA PDE Inhibitors Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA PDE Inhibitors Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA PDE Inhibitors Price and Trend Forecast (2017-2022)
11.2 EMEA PDE Inhibitors Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe PDE Inhibitors Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt PDE Inhibitors Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa PDE Inhibitors Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA PDE Inhibitors Sales Forecast by Type (2017-2022)
11.7 EMEA PDE Inhibitors Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of PDE Inhibitors
Figure EMEA PDE Inhibitors Sales Volume () by Type (2012-2022)
Figure EMEA PDE Inhibitors Sales Volume Market Share by Type (Product Category) in 2016
Figure PDE5 Product Picture
Figure PDE4 Product Picture
Figure Viagra Product Picture
Figure Cialis Product Picture
Figure Levitra Product Picture
Figure Others Product Picture
Figure EMEA PDE Inhibitors Sales Volume () by Application (2012-2022)
Figure EMEA Sales Market Share of PDE Inhibitors by Application in 2016
Figure GENITOURINARY Examples
Figure CARDIOVASCULAR DISEASES Examples
Figure NEUROLOGICAL DISEASES Examples
Figure DERMATOLOGICAL DISORDERS Examples
Figure RESPIRATORY DISEASES Examples
Figure OTHER INDICATIONS Examples
Figure EMEA PDE Inhibitors Market Size (Million USD) by Region (2012-2022)
Figure Europe PDE Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe PDE Inhibitors Revenue (Million USD) Status and Forecast by Countries
Figure Middle East PDE Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East PDE Inhibitors Revenue (Million USD) Status and Forecast by Countries
Figure Africa PDE Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa PDE Inhibitors Revenue (Million USD) Status and Forecast by Countries
Figure EMEA PDE Inhibitors Sales Volume and Growth Rate (2012-2022)
Figure EMEA PDE Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA PDE Inhibitors Market Major Players Product Sales Volume () (2012-2017)
Table EMEA PDE Inhibitors Sales Volume () of Major Players (2012-2017)
Table EMEA PDE Inhibitors Sales Share by Players (2012-2017)
Figure 2016 PDE Inhibitors Sales Share by Players
Figure 2017 PDE Inhibitors Sales Share by Players
Figure EMEA PDE Inhibitors Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA PDE Inhibitors Revenue (Million USD) by Players (2012-2017)
Table EMEA PDE Inhibitors Revenue Share by Players (2012-2017)
Table 2016 EMEA PDE Inhibitors Revenue Share by Players
Table 2017 EMEA PDE Inhibitors Revenue Share by Players
Table EMEA PDE Inhibitors Sale Price () by Players (2012-2017)
Table EMEA PDE Inhibitors Sales () and Market Share by Type (2012-2017)
Table EMEA PDE Inhibitors Sales Share by Type (2012-2017)
Figure Sales Market Share of PDE Inhibitors by Type (2012-2017)
Figure EMEA PDE Inhibitors Sales Market Share by Type (2012-2017)
Table EMEA PDE Inhibitors Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA PDE Inhibitors Revenue Share by Type (2012-2017)
Figure Revenue Market Share of PDE Inhibitors by Type in 2016
Table EMEA PDE Inhibitors Sale Price () by Type (2012-2017)
Table EMEA PDE Inhibitors Sales () and Market Share by Application (2012-2017)
Table EMEA PDE Inhibitors Sales Share by Application (2012-2017)
Figure Sales Market Share of PDE Inhibitors by Application (2012-2017)
Figure EMEA PDE Inhibitors Sales Market Share by Application in 2016
Table EMEA PDE Inhibitors Sales () and Market Share by Region (2012-2017)
Table EMEA PDE Inhibitors Sales Share by Region (2012-2017)
Figure Sales Market Share of PDE Inhibitors by Region (2012-2017)
Figure EMEA PDE Inhibitors Sales Market Share in 2016
Table EMEA PDE Inhibitors Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA PDE Inhibitors Revenue Share by Region (2012-2017)
Figure Revenue Market Share of PDE Inhibitors by Region (2012-2017)
Figure EMEA PDE Inhibitors Revenue Market Share Regions in 2016
Table EMEA PDE Inhibitors Sales Price () by Region (2012-2017)
Figure Europe PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Europe PDE Inhibitors Revenue and Growth Rate (2012-2017)
Table Europe PDE Inhibitors Sales () by Type (2012-2017)
Table Europe PDE Inhibitors Market Share by Type (2012-2017)
Figure Europe PDE Inhibitors Market Share by Type in 2016
Table Europe PDE Inhibitors Sales () by Application (2012-2017)
Table Europe PDE Inhibitors Market Share by Application (2012-2017)
Figure Europe PDE Inhibitors Market Share by Application in 2016
Table Europe PDE Inhibitors Sales () by Countries (2012-2017)
Table Europe PDE Inhibitors Sales Market Share by Countries (2012-2017)
Figure Europe PDE Inhibitors Sales Market Share by Countries (2012-2017)
Figure Europe PDE Inhibitors Sales Market Share by Countries in 2016
Table Europe PDE Inhibitors Revenue (Million USD) by Countries (2012-2017)
Table Europe PDE Inhibitors Revenue Market Share by Countries (2012-2017)
Figure Europe PDE Inhibitors Revenue Market Share by Countries (2012-2017)
Figure Europe PDE Inhibitors Revenue Market Share by Countries in 2016
Figure Germany PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure France PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure UK PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Russia PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Italy PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Benelux PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Middle East PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Middle East PDE Inhibitors Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East PDE Inhibitors Sales () by Type (2012-2017)
Table Middle East PDE Inhibitors Market Share by Type (2012-2017)
Figure Middle East PDE Inhibitors Market Share by Type (2012-2017)
Table Middle East PDE Inhibitors Sales () by Applications (2012-2017)
Table Middle East PDE Inhibitors Market Share by Applications (2012-2017)
Figure Middle East PDE Inhibitors Sales Market Share by Application in 2016
Table Middle East PDE Inhibitors Sales Volume () by Countries (2012-2017)
Table Middle East PDE Inhibitors Sales Volume Market Share by Countries (2012-2017)
Figure Middle East PDE Inhibitors Sales Volume Market Share by Countries in 2016
Table Middle East PDE Inhibitors Revenue (Million USD) by Countries (2012-2017)
Table Middle East PDE Inhibitors Revenue Market Share by Countries (2012-2017)
Figure Middle East PDE Inhibitors Revenue Market Share by Countries (2012-2017)
Figure Middle East PDE Inhibitors Revenue Market Share by Countries in 2016
Figure Saudi Arabia PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Israel PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure UAE PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Iran PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Africa PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Africa PDE Inhibitors Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa PDE Inhibitors Sales () by Type (2012-2017)
Table Africa PDE Inhibitors Sales Market Share by Type (2012-2017)
Figure Africa PDE Inhibitors Sales Market Share by Type (2012-2017)
Figure Africa PDE Inhibitors Sales Market Share by Type in 2016
Table Africa PDE Inhibitors Sales () by Application (2012-2017)
Table Africa PDE Inhibitors Sales Market Share by Application (2012-2017)
Figure Africa PDE Inhibitors Sales Market Share by Application (2012-2017)
Table Africa PDE Inhibitors Sales Volume () by Countries (2012-2017)
Table Africa PDE Inhibitors Sales Market Share by Countries (2012-2017)
Figure Africa PDE Inhibitors Sales Market Share by Countries (2012-2017)
Figure Africa PDE Inhibitors Sales Market Share by Countries in 2016
Table Africa PDE Inhibitors Revenue (Million USD) by Countries (2012-2017)
Table Africa PDE Inhibitors Revenue Market Share by Countries (2012-2017)
Figure Africa PDE Inhibitors Revenue Market Share by Countries (2012-2017)
Figure Africa PDE Inhibitors Revenue Market Share by Countries in 2016
Figure South Africa PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Nigeria PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Egypt PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Algeria PDE Inhibitors Sales () and Growth Rate (2012-2017)
Table Hanmi Science Holding PDE Inhibitors Basic Information List
Table Hanmi Science Holding PDE Inhibitors Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Hanmi Science Holding PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Hanmi Science Holding PDE Inhibitors Sales Market Share in EMEA (2012-2017)
Figure Hanmi Science Holding PDE Inhibitors Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim PDE Inhibitors Basic Information List
Table Boehringer Ingelheim PDE Inhibitors Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Boehringer Ingelheim PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Boehringer Ingelheim PDE Inhibitors Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim PDE Inhibitors Revenue Market Share in EMEA (2012-2017)
Table Takeda Pharmaceuticals PDE Inhibitors Basic Information List
Table Takeda Pharmaceuticals PDE Inhibitors Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Takeda Pharmaceuticals PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Takeda Pharmaceuticals PDE Inhibitors Sales Market Share in EMEA (2012-2017)
Figure Takeda Pharmaceuticals PDE Inhibitors Revenue Market Share in EMEA (2012-2017)
Table Pfizer PDE Inhibitors Basic Information List
Table Pfizer PDE Inhibitors Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Pfizer PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Pfizer PDE Inhibitors Sales Market Share in EMEA (2012-2017)
Figure Pfizer PDE Inhibitors Revenue Market Share in EMEA (2012-2017)
Table Omeros PDE Inhibitors Basic Information List
Table Omeros PDE Inhibitors Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Omeros PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Omeros PDE Inhibitors Sales Market Share in EMEA (2012-2017)
Figure Omeros PDE Inhibitors Revenue Market Share in EMEA (2012-2017)
Table Anacor Pharmaceuticals PDE Inhibitors Basic Information List
Table Anacor Pharmaceuticals PDE Inhibitors Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Anacor Pharmaceuticals PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Anacor Pharmaceuticals PDE Inhibitors Sales Market Share in EMEA (2012-2017)
Figure Anacor Pharmaceuticals PDE Inhibitors Revenue Market Share in EMEA (2012-2017)
Table Otsuka PDE Inhibitors Basic Information List
Table Otsuka PDE Inhibitors Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Otsuka PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Otsuka PDE Inhibitors Sales Market Share in EMEA (2012-2017)
Figure Otsuka PDE Inhibitors Revenue Market Share in EMEA (2012-2017)
Table Chiesi Farmaceutici PDE Inhibitors Basic Information List
Table Chiesi Farmaceutici PDE Inhibitors Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Chiesi Farmaceutici PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Chiesi Farmaceutici PDE Inhibitors Sales Market Share in EMEA (2012-2017)
Figure Chiesi Farmaceutici PDE Inhibitors Revenue Market Share in EMEA (2012-2017)
Table Verona Pharma PDE Inhibitors Basic Information List
Table Verona Pharma PDE Inhibitors Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Verona Pharma PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure Verona Pharma PDE Inhibitors Sales Market Share in EMEA (2012-2017)
Figure Verona Pharma PDE Inhibitors Revenue Market Share in EMEA (2012-2017)
Table NuSirt Biopharma PDE Inhibitors Basic Information List
Table NuSirt Biopharma PDE Inhibitors Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure NuSirt Biopharma PDE Inhibitors Sales () and Growth Rate (2012-2017)
Figure NuSirt Biopharma PDE Inhibitors Sales Market Share in EMEA (2012-2017)
Figure NuSirt Biopharma PDE Inhibitors Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of PDE Inhibitors
Figure Manufacturing Process Analysis of PDE Inhibitors
Figure PDE Inhibitors Industrial Chain Analysis
Table Raw Materials Sources of PDE Inhibitors Major Manufacturers in 2016
Table Major Buyers of PDE Inhibitors
Table Distributors/Traders List
Figure EMEA PDE Inhibitors Sales () and Growth Rate Forecast (2017-2022)
Figure EMEA PDE Inhibitors Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA PDE Inhibitors Price () and Trend Forecast (2017-2022)
Table EMEA PDE Inhibitors Sales () Forecast by Region (2017-2022)
Figure EMEA PDE Inhibitors Sales Market Share Forecast by Region (2017-2022)
Table EMEA PDE Inhibitors Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA PDE Inhibitors Revenue Market Share Forecast by Region (2017-2022)
Table Europe PDE Inhibitors Sales () Forecast by Countries (2017-2022)
Figure Europe PDE Inhibitors Sales Market Share Forecast by Countries (2017-2022)
Table Europe PDE Inhibitors Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe PDE Inhibitors Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East PDE Inhibitors Sales () Forecast by Countries (2017-2022)
Figure Middle East PDE Inhibitors Sales Market Share Forecast by Countries (2017-2022)
Table Middle East PDE Inhibitors Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East PDE Inhibitors Revenue Market Share Forecast by Countries (2017-2022)
Table Africa PDE Inhibitors Sales () Forecast by Countries (2017-2022)
Figure Africa PDE Inhibitors Sales Market Share Forecast by Countries (2017-2022)
Table Africa PDE Inhibitors Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa PDE Inhibitors Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA PDE Inhibitors Sales () Forecast by Type (2017-2022)
Figure EMEA PDE Inhibitors Sales Market Share Forecast by Type (2017-2022)
Table EMEA PDE Inhibitors Sales () Forecast by Application (2017-2022)
Figure EMEA PDE Inhibitors Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources